Building Blocks
This section contains fundamental products for the synthesis of organic and biological compounds. Building blocks are the essential starting materials used to construct complex molecules through various chemical reactions. They play a critical role in drug discovery, material science, and chemical research. At CymitQuimica, we offer a diverse range of high-quality building blocks to support your innovative research and industrial projects, ensuring you have the essential components for successful synthesis.
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,783 products)
- Chiral Building Blocks(1,242 products)
- Hydrocarbon Building Blocks(6,105 products)
- Organic Building Blocks(61,055 products)
Found 205383 products of "Building Blocks"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
N,N-Diethyl-3-(hydrazinecarbonyl)benzene-1-sulfonamide
CAS:Versatile small molecule scaffoldFormula:C11H17N3O3SPurity:Min. 95%Molecular weight:271.34 g/mol3-Imidazol-1-yl-propionic acid hydrochloride
CAS:Versatile small molecule scaffold
Formula:C6H9ClN2O2Purity:Min. 95%Molecular weight:176.6 g/mol(1S)-1-(4-Nitrophenyl)ethan-1-ol
CAS:(1S)-1-(4-Nitrophenyl)ethan-1-ol is an intermediate in the synthesis of a chiral alcohol. It can be prepared by hydrogenolysis of (1R)-1-phenylethanol with palladium on carbon, followed by catalytic reduction of the nitro group. The hydrogenolysis can also be carried out in the presence of lipase, which will produce a higher yield. This intermediate can then be used to synthesize other compounds, such as 4-nitroacetophenone and chiral alcohols.Formula:C8H9NO3Purity:Min. 95%Color and Shape:PowderMolecular weight:167.16 g/mol1-Phenyl-1H,4H,5H,6H-cyclopenta[C]pyrazole-3-carboxylic acid
CAS:Versatile small molecule scaffold
Formula:C13H12N2O2Purity:Min. 95%Molecular weight:228.25 g/mol3-(3-Furyl)-3-oxopropanenitrile
CAS:Versatile small molecule scaffoldFormula:C7H5NO2Purity:Min. 95%Molecular weight:135.12 g/mol3-(1,3-Benzodioxol-5-yl)-3-oxopropanenitrile
CAS:Versatile small molecule scaffoldFormula:C10H7NO3Purity:Min. 95%Molecular weight:189.16 g/mol5-Amino-6-bromo-2,3-dihydro-1H-1,3-benzodiazol-2-one
CAS:Versatile small molecule scaffoldFormula:C7H6BrN3OPurity:Min. 95%Molecular weight:228.05 g/molMethyl 4,5-dichloro-3-hydroxythiophene-2-carboxylate
CAS:Methyl 4,5-dichloro-3-hydroxythiophene-2-carboxylate is a therapeutic drug that can modulate autoimmune diseases. It has been shown to have an antigenic effect in mice with type 1 diabetes and has been used therapeutically for the treatment of autoimmune disease. This compound also inhibits the production of autoantibodies in a mouse model of systemic lupus erythematosus and may be effective in treating autoimmune diseases.Formula:C6H4Cl2O3SPurity:Min. 95%Molecular weight:227.06 g/mol4-Phenyl-3-(trifluoromethyl)-1H-pyrazole
CAS:Versatile small molecule scaffoldFormula:C10H7F3N2Purity:Min. 95%Molecular weight:212.17 g/mol6-Hydroxy-3-(methylsulfanyl)-1,2,4-triazine-5-carboxamide
CAS:Versatile small molecule scaffoldFormula:C5H6N4O2SPurity:Min. 95%Molecular weight:186.19 g/molBicyclo[4.1.0]heptane-1-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C8H12O2Purity:Min. 95%Molecular weight:140.18 g/mol5-Chloro-1,3-dimethyl-1H-pyrazole-4-carbonitrile
CAS:Versatile small molecule scaffoldFormula:C6H6ClN3Purity:Min. 95%Molecular weight:155.58 g/mol3-(2-Ethoxy-2-oxoethyl)-1H-indole-2-carboxylic acid
CAS:Versatile small molecule scaffold
Formula:C13H13NO4Purity:Min. 95%Molecular weight:247.25 g/mol2-Butyl-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C13H13NO4Purity:Min. 95%Molecular weight:247.25 g/mol(1E)-Cyclooct-1-ene-1-carbaldehyde
CAS:Versatile small molecule scaffold
Formula:C9H14OPurity:Min. 95%Molecular weight:138.21 g/molEthyl 6-bromo-2-methylpyrazolo[1,5-a]pyrimidine-3-carboxylate
CAS:Versatile small molecule scaffoldFormula:C10H10BrN3O2Purity:Min. 95%Molecular weight:284.11 g/mol2-Methyl-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C8H7N3O2Purity:Min. 95%Molecular weight:177.16 g/molN,N'-Bis(2-nitrophenyl)propanediamide
CAS:Versatile small molecule scaffoldFormula:C15H12N4O6Purity:Min. 95%Molecular weight:344.28 g/mol5-Amino-4H,7H-pyrazolo[1,5-a]pyrimidin-7-one
CAS:Versatile small molecule scaffold
Formula:C6H6N4OPurity:Min. 95%Molecular weight:150.14 g/mol5-Amino-2-methyl-4H,7H-pyrazolo[1,5-a]pyrimidin-7-one
CAS:Versatile small molecule scaffoldFormula:C7H8N4OPurity:Min. 95%Molecular weight:164.16 g/mol2-Oxocyclohexane-1-sulfonamide
CAS:Versatile small molecule scaffoldFormula:C6H11NO3SPurity:Min. 95%Molecular weight:177.22 g/mol2-Methylimidazo[2,1-b][1,3,4]thiadiazole-6-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C6H5N3O2SPurity:Min. 95%Molecular weight:183.19 g/molDimethylimidazo[2,1-b][1,3,4]thiadiazole-5-carboxylic acid
CAS:Versatile small molecule scaffold
Formula:C7H7N3O2SPurity:Min. 95%Molecular weight:197.22 g/molcis-3-Carbomethoxycyclopentane-1-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C8H12O4Purity:Min. 95%Molecular weight:172.18 g/molMethyl (3S)-3-amino-5-methylhexanoate hydrochloride
CAS:Versatile small molecule scaffoldFormula:C8H18ClNO2Purity:Min. 95%Molecular weight:195.69 g/mol3-Hydroxy-N,N-dimethyl-2-phenylpropanamide
CAS:Versatile small molecule scaffoldFormula:C11H15NO2Purity:Min. 95%Molecular weight:193.24 g/moltert-Butyl N-(2-bromoacetyl)carbamate
CAS:Versatile small molecule scaffoldFormula:C7H12BrNO3Purity:Min. 95%Molecular weight:238.08 g/mol5,6-Dimethyl-3,4-dihydro-2H-1-benzopyran-4-one
CAS:Versatile small molecule scaffoldFormula:C11H12O2Purity:Min. 95%Molecular weight:176.21 g/mol3-(3-Chlorophenyl)-2-oxopropanoic acid
CAS:3-(3-Chlorophenyl)-2-oxopropanoic acid is a diastereomer of 2-phenylpropanoic acid. It is used in the synthesis of diketopiperazines, which are analogues of amphetamines. The synthesis proceeds by the addition of ethyl chloroacetate to α-chloroacrylic acid followed by reaction with cyclohexanol and then reduction with lithium aluminum hydride. The stereoselectivity of this reaction is determined by the enantioselective transfer of a proton from the hydroxyl group to the adjacent carbonyl group. This process occurs more readily when an enantiomerically pure chiral catalyst is used, leading to a diastereoselective synthesis.Formula:C9H7ClO3Purity:Min. 95%Molecular weight:198.6 g/molEthyl 4-phenylbut-2-ynoate
CAS:Ethyl 4-phenylbut-2-ynoate is a drug that has been shown to have an inhibitory effect on cancer cells. It belongs to the class of pharmacological agents, which are agents for treating diseases. Ethyl 4-phenylbut-2-ynoate is used to treat certain cancers, including breast cancer and non-small cell lung cancer. This drug also inhibits histone deacetylase activity, thereby preventing transcription. The clinical use of this drug is limited due to its low bioavailability. Pharmacokinetic studies have shown that this drug is eliminated rapidly after administration and has a short half life of approximately 1 hour. There are no known regulatory proteins for this drug or any modifications in its fatty acids or phenotype.Formula:C12H12O2Purity:Min. 95%Molecular weight:188.22 g/mol8-(Benzyloxy)imidazo[1,2-a]pyridine
CAS:8-(Benzyloxy)imidazo[1,2-a]pyridine is a potent and selective bradykinin B2 receptor antagonist. It is an orally active compound that has been found to be absorbed in the gastrointestinal tract. 8-(Benzyloxy)imidazo[1,2-a]pyridine has shown antagonistic activities against bradykinin B2 receptors by binding to the receptor’s nucleophilic site. This binding causes a conformational change in the receptor, preventing it from being activated. 8-(Benzyloxy)imidazo[1,2-a]pyridine also has a high affinity for the bradykinin B2 receptor and can be used as an organocatalyst in organic chemistry reactions.
Formula:C14H12N2OPurity:Min. 95%Molecular weight:224.26 g/mol3-(Pyridin-3-ylmethoxy)pyridin-2-amine
CAS:Versatile small molecule scaffoldFormula:C11H11N3OPurity:Min. 95%Molecular weight:201.22 g/mol3-(Pyridin-4-ylmethoxy)pyridin-2-amine
CAS:Versatile small molecule scaffoldFormula:C11H11N3OPurity:Min. 95%Molecular weight:201.22 g/mol3-Chloro-2-ethynylpyridine
CAS:Versatile small molecule scaffold
Formula:C7H4ClNPurity:Min. 95%Molecular weight:137.56 g/mol3-Bromo-2-ethynylpyridine
CAS:Versatile small molecule scaffoldFormula:C7H4BrNPurity:Min. 95%Molecular weight:182.02 g/mol1-Chloro-5,6,7-trimethyl-6H-pyrrolo[3,4-d]pyridazine hydrochloride
CAS:Versatile small molecule scaffoldFormula:C9H11Cl2N3Purity:Min. 95%Molecular weight:232.11 g/mol2,2,2-Trifluoroethyl N-(3-methylphenyl)carbamate
CAS:Versatile small molecule scaffoldFormula:C10H10F3NO2Purity:Min. 95%Molecular weight:233.19 g/mol3-Amino-1-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)thiourea
CAS:Versatile small molecule scaffoldFormula:C12H15N5OSPurity:Min. 95%Molecular weight:277.35 g/mol1-Benzyl-4-(hydroxymethyl)pyrrolidin-2-one
CAS:1-Benzyl-4-(hydroxymethyl)pyrrolidin-2-one is an experimental analgesic drug. It is a prodrug that undergoes several metabolic transformations, including oxidation, hydroxylation, and reduction to form the active metabolite 1-benzylpyrrolidin-2(3H)-one. This compound has been shown to have potent antihypertensive effects in animals as well as antidepressant activity. The optical isomer of this compound has also been shown to have anticonvulsant effects in animals.Formula:C12H15NO2Purity:Min. 95%Molecular weight:205.25 g/mol5-Oxo-1-(1-phenylethyl)pyrrolidine-3-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C13H15NO3Purity:Min. 95%Molecular weight:233.26 g/moltert-Butyl 2-oxo-1,2-dihydropyridine-1-carboxylate
CAS:Versatile small molecule scaffoldFormula:C10H13NO3Purity:Min. 95%Molecular weight:195.21 g/mol4-[(4-Chlorophenyl)sulfanyl]benzonitrile
CAS:Versatile small molecule scaffoldFormula:C13H8ClNSPurity:Min. 95%Molecular weight:245.73 g/molrac-(2R,5S)-5-(Methoxycarbonyl)oxolane-2-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C7H10O5Purity:Min. 95%Molecular weight:174.2 g/mol2-(4-Chloro-3-methoxyphenyl)ethan-1-amine
CAS:Controlled ProductVersatile small molecule scaffoldFormula:C9H12ClNOPurity:Min. 95%Molecular weight:185.65 g/mol3-Amino-6-bromo-3,4-dihydroquinazolin-4-one
CAS:Versatile small molecule scaffoldFormula:C8H6BrN3OPurity:Min. 95%Molecular weight:240.06 g/mol3-[Benzyl(methyl)amino]-2,2-dimethylpropanal
CAS:Versatile small molecule scaffoldFormula:C13H19NOPurity:Min. 95%Molecular weight:205.3 g/molMethyl 7-chlorothieno[3,2-b]pyridine-6-carboxylate
CAS:Versatile small molecule scaffoldFormula:C9H6ClNO2SPurity:Min. 95%Molecular weight:227.67 g/mol5-(Trifluoromethyl)thiophene-3-carbaldehyde
CAS:Versatile small molecule scaffoldFormula:C6H3F3OSPurity:Min. 95%Molecular weight:180.15 g/mol2-(4-Chlorophenyl)-2-(phenylamino)acetamide
CAS:Versatile small molecule scaffoldFormula:C14H13ClN2OPurity:Min. 95%Molecular weight:260.72 g/mol1-(4-Iodo-phenyl)-piperazine
CAS:Controlled Product1-(4-Iodo-phenyl)-piperazine is a radiopharmaceutical that is used to image the myocardium. It has been radioiodinated with Iodine-123 and has high specific activity, which allows for excellent imaging of the heart. The iodine content in this compound can be used as a measure of myocardial function. 1-(4-Iodo-phenyl)-piperazine has been studied in patients with coronary artery disease and congestive heart failure (CHF). In these studies, it was found to have a low uptake in healthy tissues such as the liver, kidney, and spleen. This agent also does not show any significant uptake in the brain or skeletal muscle.Formula:C10H13IN2Purity:Min. 95%Molecular weight:288.13 g/mol
![1-Phenyl-1H,4H,5H,6H-cyclopenta[C]pyrazole-3-carboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FWDA19736.webp&w=3840&q=75)
![Bicyclo[4.1.0]heptane-1-carboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FWDA25965.webp&w=3840&q=75)
![Ethyl 6-bromo-2-methylpyrazolo[1,5-a]pyrimidine-3-carboxylate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FWDA31936.webp&w=3840&q=75)
![2-Methyl-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FWDA31938.webp&w=3840&q=75)
![5-Amino-4H,7H-pyrazolo[1,5-a]pyrimidin-7-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FWDA33542.webp&w=3840&q=75)
![5-Amino-2-methyl-4H,7H-pyrazolo[1,5-a]pyrimidin-7-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FWDA33543.webp&w=3840&q=75)
![2-Methylimidazo[2,1-b][1,3,4]thiadiazole-6-carboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FWDA35606.webp&w=3840&q=75)
![Dimethylimidazo[2,1-b][1,3,4]thiadiazole-5-carboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FWDA35616.webp&w=3840&q=75)
![8-(Benzyloxy)imidazo[1,2-a]pyridine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FWDA42816.webp&w=3840&q=75)
![1-Chloro-5,6,7-trimethyl-6H-pyrrolo[3,4-d]pyridazine hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FWDA44191.webp&w=3840&q=75)
![4-[(4-Chlorophenyl)sulfanyl]benzonitrile](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FWDA46181.webp&w=3840&q=75)
![3-[Benzyl(methyl)amino]-2,2-dimethylpropanal](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FWDA51605.webp&w=3840&q=75)
![Methyl 7-chlorothieno[3,2-b]pyridine-6-carboxylate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FWDA51652.webp&w=3840&q=75)
